Are mega M&As back in pharma?
Ranjith Gopinathan, Life Sciences Programme Manager at Frost & Sullivan, comments on the Novartis – GSK deal
24-Apr-2014 -
“The pharmaceutical industry is witnessing a new wave of mergers and acquisitions activities, especially mega M&As. Big pharma companies have historically been fighting, albeit with little success, on various issues such as patent expiry of blockbuster molecules, regulatory hurdles, generics ...
acquisitions
pharmaceutical industry